Page last updated: 2024-12-11

dbm-819

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

DBM-819: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9842701
SCHEMBL ID4446889
MeSH IDM0378175

Synonyms (9)

Synonym
zz64t6xqsm ,
unii-zz64t6xqsm
1-propanol, 3-((2,3-dihydro-1-(4-methoxy-2-methylphenyl)-6-methyl-1h-pyrrolo(3,2-c)quinolin-4-yl)amino)-
331686-58-9
dbm-819
SCHEMBL4446889
Q27295955
3-[[1-(4-methoxy-2-methylphenyl)-6-methyl-2,3-dihydropyrrolo[3,2-c]quinolin-4-yl]amino]propan-1-ol
AKOS040751412

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"The dose-dependent pharmacokinetic parameters of DBM-819 were evaluated after intravenous (5, 10 and 20 mg/kg) and oral (10, 20 and 50 mg/kg) administrations of the drug to rats."( Dose-dependent pharmacokinetics of a new reversible proton pump inhibitor, DBM-819, after intravenous and oral administration to rats: hepatic first-pass effect.
Kim, EJ; Kim, SO; Lee, DH; Lee, MG; Lim, H, 2001
)
0.8

Bioavailability

ExcerptReferenceRelevance
"86% of oral dose was not absorbed and the extent of absolute oral bioavailability (F) was estimated to be 46."( Dose-dependent pharmacokinetics of a new reversible proton pump inhibitor, DBM-819, after intravenous and oral administration to rats: hepatic first-pass effect.
Kim, EJ; Kim, SO; Lee, DH; Lee, MG; Lim, H, 2001
)
0.54
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.56 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]